• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低温体外循环期间心房利钠因子的药代动力学及作用

Pharmacokinetics and effects of atrial natriuretic factor during hypothermic cardiopulmonary bypass.

作者信息

Hynynen M, Olkkola K T, Palojoki R, Tikkanen I, Fyhrquist F

机构信息

Department of Anaesthesia, Helsinki University Central Hospital, Finland.

出版信息

Eur J Clin Pharmacol. 1992;43(6):647-50. doi: 10.1007/BF02284966.

DOI:10.1007/BF02284966
PMID:1493848
Abstract

The pharmacokinetics of a bolus dose of synthetic atrial natriuretic factor (ANF) 50 micrograms and its effects on urine output, blood pressure and plasma renin activity have been studied in 5 patients undergoing hypothermic cardiopulmonary bypass for cardiac surgery. The half-lives of the fast and slow components were 2.4 min and 14.2 min, respectively. The volume of the central compartment was 16.7 l and the volume of distribution at steady-state was 38.9 l. The total plasma clearance was 3.8 l.min-1. ANF significantly increased urine output and decreased blood pressure, but it did not affect plasma renin activity.

摘要

对5例接受心脏手术低温心肺转流的患者,研究了静脉注射50微克合成心钠素(ANF)的药代动力学及其对尿量、血压和血浆肾素活性的影响。快、慢成分的半衰期分别为2.4分钟和14.2分钟。中央室容积为16.7升,稳态分布容积为38.9升。总血浆清除率为3.8升·分钟⁻¹。心钠素显著增加尿量并降低血压,但不影响血浆肾素活性。

相似文献

1
Pharmacokinetics and effects of atrial natriuretic factor during hypothermic cardiopulmonary bypass.低温体外循环期间心房利钠因子的药代动力学及作用
Eur J Clin Pharmacol. 1992;43(6):647-50. doi: 10.1007/BF02284966.
2
Renal and vascular effects of atrial natriuretic factor during cardiopulmonary bypass.心肺转流期间心房利钠因子的肾脏和血管效应
Chest. 1991 Nov;100(5):1203-9. doi: 10.1378/chest.100.5.1203.
3
Influence of hypothermic cardiopulmonary bypass on atrial natriuretic factor levels.
Can J Anaesth. 1989 Sep;36(5):545-53. doi: 10.1007/BF03005384.
4
Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
J Cardiovasc Pharmacol. 1992 May;19(5):691-700.
5
Pharmacokinetics, hemodynamic, renal, and neurohormonal effects of atrial natriuretic factor in experimental heart failure.心房利钠因子在实验性心力衰竭中的药代动力学、血流动力学、肾脏及神经激素效应
Clin Invest Med. 1990 Jun;13(3):111-8.
6
The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade.125I-心房利钠因子在麻醉大鼠体内的药代动力学。坎多沙坦抑制中性内肽酶及阻断ANF-C受体的作用。
Biochem Pharmacol. 1992 Sep 25;44(6):1013-22. doi: 10.1016/0006-2952(92)90362-m.
7
Effects of incremental infusions of atrial natriuretic factor on aldosterone, renin, and blood pressure in humans.心房利钠因子递增输注对人体醛固酮、肾素及血压的影响。
Hypertension. 1988 Oct;12(4):462-7. doi: 10.1161/01.hyp.12.4.462.
8
Effects and pharmacokinetics of bolus injections of atrial natriuretic factor in normal volunteers.正常志愿者静脉推注心房利钠因子的效应及药代动力学
J Cardiovasc Pharmacol. 1988 Jun;11(6):635-42. doi: 10.1097/00005344-198806000-00002.
9
Pharmacokinetics of doxacurium during normothermic and hypothermic cardiopulmonary bypass surgery.
Can J Anaesth. 1998 Jun;45(6):515-20. doi: 10.1007/BF03012700.
10
Atrial natriuretic factor in normothermic and hypothermic cardiopulmonary bypass.正常体温和低温体外循环中的心房利钠因子
Perfusion. 2004 May;19(3):157-62. doi: 10.1191/0267659104pf732oa.

本文引用的文献

1
Effect of hypothermia on drug metabolism. In vitro studies with propranolol and verapamil.低温对药物代谢的影响。普萘洛尔和维拉帕米的体外研究。
Pharmacology. 1980;20(2):95-100. doi: 10.1159/000137349.
2
Noncompartmental determination of the steady-state volume of distribution for any mode of administration.非房室模型法测定任何给药方式下的稳态分布容积。
J Pharm Sci. 1982 Mar;71(3):372-3. doi: 10.1002/jps.2600710332.
3
Plasma clearance and effects of alpha-hANP infused in patients with end-stage renal failure.晚期肾衰竭患者输注α-心钠素后的血浆清除率及效应
Am J Physiol. 1988 Jun;254(6 Pt 2):F895-9. doi: 10.1152/ajprenal.1988.254.6.F895.
4
Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide.
FEBS Lett. 1988 May 9;232(1):1-8. doi: 10.1016/0014-5793(88)80375-2.
5
Effect of posture on clearance of atrial natriuretic peptide from plasma.姿势对血浆中的心钠素清除率的影响。
J Clin Endocrinol Metab. 1987 Dec;65(6):1095-7. doi: 10.1210/jcem-65-6-1095.
6
Hemodynamic, renal, and hormonal responses to alpha-human atrial natriuretic peptide in patients with congestive heart failure.充血性心力衰竭患者对α-人心房利钠肽的血流动力学、肾脏及激素反应。
Clin Pharmacol Ther. 1987 Aug;42(2):142-7. doi: 10.1038/clpt.1987.124.
7
Pharmacokinetics of synthetic atrial natriuretic peptides in normal men.合成心房利钠肽在正常男性中的药代动力学
Clin Pharmacol Ther. 1987 Jun;41(6):671-7. doi: 10.1038/clpt.1987.94.
8
The pharmacokinetics of alpha-human atrial natriuretic polypeptide in healthy subjects.健康受试者中α-人心房利钠多肽的药代动力学
Eur J Clin Pharmacol. 1986;31(1):101-3. doi: 10.1007/BF00870995.
9
Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man.人α-人心房利钠肽的代谢清除率和血浆半衰期
Life Sci. 1986 May 19;38(20):1827-33. doi: 10.1016/0024-3205(86)90137-2.
10
Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.心房利钠激素、肾素-醛固酮轴与血压-电解质稳态。
N Engl J Med. 1985 Nov 21;313(21):1330-40. doi: 10.1056/NEJM198511213132106.